Search

Author/Creator Faoro, Leonardo

1. Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 8 (August 2021)

Authors:
Brose, Marcia S; Robinson, Bruce; Sherman, Steven I; Krajewska, Jolanta; Lin, Chia-Chi; Vaisman, Fernanda; Hoff, Ana O; Hitre, Erika; Bowles, Daniel W; Hernando, Jorge; Faoro, Leonardo; Banerjee, Kamalika; Oliver, Jennifer W; Keam, Bhumsuk; Capdevila, Jaume
Journal:
Lancet oncology
Issue:
Volume 22:Issue 8(2021)
Page Start:
1126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search